Your browser doesn't support javascript.
loading
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial.
Benedikt, Martin; Mangge, Harald; Aziz, Faisal; Curcic, Pero; Pailer, Sabine; Herrmann, Markus; Kolesnik, Ewald; Tripolt, Norbert J; Pferschy, Peter N; Wallner, Markus; Zirlik, Andreas; Sourij, Harald; von Lewinski, Dirk.
Afiliación
  • Benedikt M; Department of Internal Medicine, Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
  • Mangge H; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Aziz F; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
  • Curcic P; Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.
  • Pailer S; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Herrmann M; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Kolesnik E; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Tripolt NJ; Department of Internal Medicine, Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
  • Pferschy PN; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
  • Wallner M; Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.
  • Zirlik A; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
  • Sourij H; Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.
  • von Lewinski D; Department of Internal Medicine, Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria.
Cardiovasc Diabetol ; 22(1): 166, 2023 07 05.
Article en En | MEDLINE | ID: mdl-37407956
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Austria